- rhTSH in Thyroid Cancer
-
Choe W
- KMID: 2199898
- J Korean Soc Endocrinol.
- 2002 Apr;17(2):143-151.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Radioiodine Therapy for Thyroid Cancer
-
Bae SK
- KMID: 2313024
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):132-140.
Well-differentiated thyroid cancer is the most common endocrine malignancy with an increasing incidence. Most patients with well-differentiated thyroid caner have a favorable prognosis with high survival rate. While surgery and... -
- CITED
-
- Close
- SHARE
-
- Close
- Value of the Serum Thyroglobulin Level Alteration at the First High Dose Radioiodine Treatment in Patients with Differentiated Thyroid Carcinoma
-
Nam HY, Kim IJ, Kim YK, Kim SJ, Jun S, Kim BS
- KMID: 2313104
- Nucl Med Mol Imaging.
- 2009 Aug;43(4):294-300.
PURPOSE: The purpose of this study was to evaluate if short-term serum thyroglobulin (Tg) elevation after radioiodine administration can predict successful radioiodine remnant ablation (RRA) and whether comparable RRA effectiveness... -
- CITED
-
- Close
- SHARE
-
- Close
- Economic Evaluation of Recombinant Human Thyroid Stimulating Hormone Stimulation vs. Thyroid Hormone Withdrawal Prior to Radioiodine Ablation for Thyroid Cancer: The Korean Perspective
-
Sohn SY, Jang HW, Cho YY, Kim SW, Chung JH
- KMID: 2169663
- Endocrinol Metab.
- 2015 Dec;30(4):531-542.
- doi: 10.3803/EnM.2015.30.4.531
BACKGROUND: Previous studies have suggested that recombinant human thyroid stimulating hormone (rhTSH) stimulation is an acceptable alternative to thyroid hormone withdrawal (THW) when radioiodine remnant ablation is planned for thyroid... -
- CITED
-
- Close
- SHARE
-
- Close
- A Retrospective Review of the Effectiveness of Recombinant Human TSH-Aided Radioiodine Treatment of Differentiated Thyroid Carcinoma
-
Na MA, Shin SH, Kang YH, Son SM, Kim IJ, Kim YK
- KMID: 2200842
- J Korean Soc Endocrinol.
- 2006 Aug;21(4):274-280.
- doi: 10.3803/jkes.2006.21.4.274
BACKGROUND: The aim of the study was to evaluate the biochemical effects of recombinant human thyroid stimulating hormone (rhTSH) as an adjunct to radioiodine (RI) treatment of a differentiated thyroid... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of the Pharmacokinetics of Recombinant Human TSH in Patients with Thyroid Papillary Carcinoma
-
Jung TS, Jung HS, Jung JH, Chung YJ, Oh EY, Min YK, Lee MS, Lee MK, Kim KW, Chung JH
- KMID: 2200732
- J Korean Soc Endocrinol.
- 2006 Jun;21(3):204-212.
- doi: 10.3803/jkes.2006.21.3.204
BACKGROUND: Individual variations of the pharmacokinetics of recombinant human TSH (rhTSH) might influence the efficacy of the radioactive iodine (RAI) uptake. We studied to investigate the individual pharmacokinetics of rhTSH... -
- CITED
-
- Close
- SHARE
-
- Close
- Does 131I Radioactivity Interfere with Thyroglobulin Measurement in Patients Undergoing Radioactive Iodine Therapy with Recombinant Human TSH?
-
Park S, Bang JI, Lee HY, Kim SE
- KMID: 2313258
- Nucl Med Mol Imaging.
- 2015 Jun;49(2):122-126.
- doi: 10.1007/s13139-014-0317-x
OBJECTIVES: Recombinant human thyroid-stimulating hormone (rhTSH) is widely used in radioactive iodine therapy (RIT) to avoid side effects caused by hypothyroidism during the therapy. Owing to RIT with rhTSH, serum... -
- CITED
-
- Close
- SHARE
-
- Close
- Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression
-
Sohn SY, Joung JY, Cho YY, Park SM, Jin SM, Chung JH, Kim SW
- KMID: 2407086
- Endocrinol Metab.
- 2015 Sep;30(3):343-351.
- doi: 10.3803/EnM.2015.30.3.343
BACKGROUND: There are limited data about whether patients who receive initial treatment for differentiated thyroid cancer (DTC) gain or lose weight during long-term follow-up under thyroid stimulating hormone (TSH) suppression.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of I-131 Biokinetics after Recombinant Human TSH Stimulation and Thyroid Hormone Withdrawal Measured by External Detector in Patients with Differentiated Thyroid Cancer
-
Kairemo K, Kangasmäki A, Bom HS
- KMID: 2432251
- Chonnam Med J.
- 2019 Jan;55(1):20-24.
- doi: 10.4068/cmj.2019.55.1.20
The aim of this study was to compare radioactive iodine (I-131) biokinetics after recombinant human TSH stimulation (rhTSH) and thyroid hormone withdrawal (THW) in patients with differentiated thyroid cancer (DTC).... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Clinical Factors for the Determination of Optimal Serum Level of Thyrotropin After Recombinant Human Thyroid-Stimulating Hormone Administration
-
Son SH, Lee SW, Jung JH, Kim CY, Kim DH, Jeong SY, Ahn BC, Lee J
- KMID: 2132231
- Nucl Med Mol Imaging.
- 2015 Dec;49(4):268-275.
- doi: 10.1007/s13139-015-0348-y
PURPOSE: To determine the optimal levels of thyroidstimulating hormone (TSH) levels after administration of recombinant human TSH (rhTSH) to patients with differentiated thyroid cancer (DTC), we have analyzed the clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors That Influence TSH Levels after Thyrogen Injection before RAI Therapy
-
Kim EY, Yun JS
- KMID: 2375438
- Korean J Endocr Surg.
- 2014 Dec;14(4):177-183.
- doi: 10.0000/kaes.2014.14.4.177
PURPOSE: Radioactive iodine therapy was used for detection and destruction of remnant normal of malignant thyroid tissue after thyroidectomy for differentiated thyroid gland cancer. To achieve a high level of... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Usefulness of the Second Generation TSH-Binding Inhibitory Immunoglobulin Assay Using Recombinant Human TSH Receptor in Patients with Graves' Disease
-
Huh JE, Suk JH, Kim MK, Choi IJ, Son SM, Kim IJ, Kim YK
- KMID: 1479204
- J Korean Endocr Soc.
- 2008 Jun;23(3):179-185.
- doi: 10.3803/jkes.2008.23.3.179
BACKGROUND AND AIM: Detection of TSH receptor antibody in patients with Graves' disease (GD) has been widely used in clinical practice. This has been performed mostly by commercial radio-receptor assays... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Thyroglobulin Measurements Using Three Different Immunoassay Kits: A BRAMHS Tg-Plus RIA Kit, a BRAMHS hTg Sensitive Kryptor Kit, and a Beckman Coulter ACCESS Immunoassay Kit
-
Kim M, Jeon MJ, Kim WG, Lee JJ, Ryu JS, Cho EJ, Ko DH, Lee W, Chun S, Min WK, Kim TY, Shong YK, Kim WB
- KMID: 2352987
- Endocrinol Metab.
- 2016 Sep;31(3):462-468.
- doi: 10.3803/EnM.2016.31.3.462
BACKGROUND: Second-generation thyroglobulin immunometric assays (Tg-IMAs) have been developed with improved sensitivity. Our aim was to compare the diagnostic value of Tg-IMA measurements using a Kryptor (BRAHMS AG) kit (Tg-K)... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Significance of Diffuse Intrathoracic Uptake on Post-Therapy I-131 Scans in Thyroid Cancer Patients
-
Choi HS, Kim SH, Park SY, Park HL, Seo YY, Choi WH
- KMID: 2139219
- Nucl Med Mol Imaging.
- 2014 Mar;48(1):63-71.
PURPOSE: The purpose of this study was to identify the frequency and possible cause of diffuse intrathoracic uptake on post-therapy I-131 scans in thyroid cancer patients. METHODS: We retrospectively reviewed 781... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Influence on the Liver Function Between Thyroid Hormone Withdrawal and rh-TSH Before High-Dose Radioiodine Therapy in Patients with Well-Differentiated Thyroid Cancer
-
Han YH, Lim ST, Yun KN, Yim SK, Kim DW, Jeong HJ, Sohn MH
- KMID: 2052003
- Nucl Med Mol Imaging.
- 2012 Jun;46(2):89-94.
PURPOSE: An elevated thyroid stimulating hormone level (TSH) is essential to stimulate the uptake of radioiodine into thyroid remnants and metastases of thyroid cancer when a patient undergoes high-dose radioiodine... -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative Adjuvant Therapy and Follow-Up of Thyroid Carcinoma
-
Yi KH
- KMID: 2065214
- J Korean Med Assoc.
- 2004 Dec;47(12):1183-1196.
- doi: 10.5124/jkma.2004.47.12.1183
Differentiated thyroid cancer is usually a curable disease, for which treatment modalities such as surgery, radioiodine, and thyroid hormone have been used for the last 50 years, yet little consensus... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Thyroglobulin Levels Predicting Recurrence and Distant Metastasis after Surgery in Patients with Differentiated Thyroid Cancer
-
Kim KS, Ryu JS, Hong SJ, Kim WB, Shong YK
- KMID: 2331171
- J Korean Soc Endocrinol.
- 2003 Apr;18(2):153-165.
BACKGROUND: Reports on serum thyroglobulin(Tg) levels being used to predict recurrence or distant metastasis during the follow-up of patients with differentiated thyroid cancer(DTC) has been inconsistent. In addition, there have... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer
-
Choi S, Na CJ, Kim J, Han YH, Kim HK, Jeong HJ, Sohn MH, Lim ST
- KMID: 2313257
- Nucl Med Mol Imaging.
- 2015 Jun;49(2):115-121.
- doi: 10.1007/s13139-014-0308-y
PURPOSE: High-dose radioiodine treatment (HD-RIT) after injection of recombinant human thyroid stimulating hormone (rh-TSH) has become widely used. This study compared the therapeutic efficacy of HD-RIT and clinical parameters between... -
- CITED
-
- Close
- SHARE
-
- Close
